{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:33:49Z","timestamp":1792643629467,"version":"4.5.0"},"reference-count":10,"publisher":"Japan Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1507\/endocrj.ej15-0275","type":"journal-article","created":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T18:13:24Z","timestamp":1435688004000},"page":"811-816","source":"Crossref","is-referenced-by-count":157,"title":["Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment"],"prefix":"10.1507","volume":"62","author":[{"given":"Itsuro","family":"Endo","sequence":"first","affiliation":[{"name":"Department of Hematology, Endocrinology & Metabolism Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima 770-8503 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Fujii Memorial Institute of Medical Sciences, Tokushima University, Tokushima 770-8503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Ozono","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Osaka University Graduate School of Medicine, Suita 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Namba","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Osaka University Graduate School of Medicine, Suita 565-0871, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Inoue","sequence":"additional","affiliation":[{"name":"Third Department of Medicine, Teikyo University Chiba Medical Center, Ichihara 299-0111, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Third Department of Medicine, Teikyo University Chiba Medical Center, Ichihara 299-0111, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Yamauchi","sequence":"additional","affiliation":[{"name":"Internal Medicine 1, Shimane University Faculty of Medicine, Izumo 693-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitsugu","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Internal Medicine 1, Shimane University Faculty of Medicine, Izumo 693-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Minagawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Chiba Children&rsquo;s Hospital, Chiba 266-0007, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimi","family":"Michigami","sequence":"additional","affiliation":[{"name":"Department of Bone and Mineral Research, Research Institute, Osaka Medical Center for Maternal and Child Health, Izumi 594-1101, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Public Health, Saitama Medical University Faculty of Medicine, Iruma 350-0495, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Fujii Memorial Institute of Medical Sciences, Tokushima University, Tokushima 770-8503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, et al. (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. <i>J Bone Miner Res <\/i>19: 429-435.","DOI":"10.1359\/JBMR.0301264"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hori M, Shimizu Y, Fukumoto S (2011) Minireview: fibroblast growth factor 23 in phosphate homeostasis and bone metabolism. <i>Endocrinology <\/i>152: 4-10.","DOI":"10.1210\/en.2010-0800"},{"key":"3","unstructured":"3. Hashimoto S, Fukutomi K, Nagai M, Nakamura Y, Yanagawa H, et al. (1991) [A method of interval estimation for number of patients in the nationwide epidemiological survey on intractable diseases]. <i>Nihon Koshu Eisei Zasshi <\/i>38: 880-883 (In Japanese)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, et al. (2002) Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. <i>J Clin Endocrinol Metab <\/i>87: 4957-4960.","DOI":"10.1210\/jc.2002-021105"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Carpenter TO (1997) New perspectives on the biology and treatment of X-linked hypophosphatemic rickets. <i>Pediatr Clin North Am <\/i>44: 443-466.","DOI":"10.1016\/S0031-3955(05)70485-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Endo I, Fukumoto S, Ozono K, Namba N, Tanaka H, et al. (2008) Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement. <i>Bone <\/i>42: 1235-1239.","DOI":"10.1016\/j.bone.2008.02.014"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Imel EA, Peacock M, Pitukcheewanont P, Heller HJ, Ward LM, et al. (2006) Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. <i>J Clin Endocrinol Metab <\/i>91: 2055-2061.","DOI":"10.1210\/jc.2005-2105"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Jiang Y, Xia WB, Xing XP, Silva BC, Li M, et al. (2012) Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature. <i>J Bone Miner Res <\/i>27: 1967-1975.","DOI":"10.1002\/jbmr.1642"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Carpenter TO, Imel EA, Ruppe MD, Weber TJ, Klausner MA, et al. (2014) Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia. <i>J Clin Invest <\/i>124: 1587-1597.","DOI":"10.1172\/JCI72829"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sato K, Shiraki M (1998) Saccharated ferric oxide-induced osteomalacia in Japan: iron-induced osteopathy due to nephropathy. <i>Endocr J <\/i>45: 431-439.","DOI":"10.1507\/endocrj.45.431"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/62\/9\/62_EJ15-0275\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T10:49:50Z","timestamp":1498214990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/62\/9\/62_EJ15-0275\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej15-0275","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}